SuperbaTM 2 500 mg SGC Bovine Vanilla
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Euphausia superba Source : Euphausia superba oil (body) | 500 mg | Not calculated |
Non-medicinal ingredients
Eau, Sorbitol, glycérol, Gélatine, Ethyl Vanillin, Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 5 Capsule | 1 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 9 years | 1 Capsule | 1 Tous les jours |
| Adultes | Not specified | 3 Capsule | 1 Tous les jours |
| Adolescentes | minimum: 13 years ; maximum: 18 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relive symptoms of dysmenorrhea and premenstrual syndrome. Helps to relieve symptoms of premenstrual syndrome. Helps to maintain cardiovascular health. Helps to reduce serum triglycerides/triacylglycerols in conjunction with conventional statin therapy. Helps to reduce the levels of LDL cholesterol in conjunction with conventional statin therapy. Helps to increase the levels of HDL cholesterol in conjunction with conventional statin therapy. Helps to reduce pain associated with osteoarthritis. Helps to reduce C-reactive protein levels, a clinical marker of inflammation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Superba TM Krill Oil, SuperbaTM 2 500 mg SGC Bovine
- Licence holder
- Aker BioMarine Human Ingredients AS
- NPN or DIN-HM
- 80051985
- Status
- Active licence
- Licence date
- 19 June 2014
- Revision date
- 19 August 2024
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80051985
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “SuperbaTM 2 500 mg SGC Bovine Vanilla”, https://compoatlas.com/en/supplements/canada/80051985-superbatm-2-500-mg-sgc-bovine-vanilla, updated 19 August 2024.